Glycomics And Glycobiology Market Size

1. Glycomics And Glycobiology Market Size & Growth | Forecast 2022, 2029 Is So Famous, But Why? Global Glycomics/glycobiology market is Segmented By Product(Enzymes, Glycosidases & Neuramidases, Glycosyltransferases & Sialytransferases, Other Enzymes (Carbohydrate kinases, carbohydrate sulfotransferases, protein sulfotransferases, and sulfatases)), Instruments, Mass Spectrometry Instruments, Chromatography Instruments, Arrays, Other Instruments (electrophoresis instruments, NMR instruments, and HPLC columns), Kits, Glycan Releasing Kits, Glycan Labeling Kits, Glycan Purification Kits, Other Kits (glycan detection kits, glycan enrichment kits, and glycan sample preparation kits), Carbohydrates, Oligosaccharides, Monosaccharides, Other Carbohydrates (rare sugars, glycoproteins, glycolipids, and glycol peptides), Reagents & Chemicals), By Application (Drug Discovery & Development, Disease Diagnostics, Other Applications (virology, cell biology, and microbiology)), By End-User( Hospitals, Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Laboratories) By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029 Market Overview The Global "Glycomics/Glycobiology Market" is Expected to reach at a high CAGR 14.1 % during the forecasting period (2022 -2029). Glycomics or Glycobiology is the study of the structure, biology, and function of saccharides which are widely distributed in nature and regarded as glycans. Glycans are found in all living organisms. Glycobiology is a rapidly progressing biological area of interest for various fields like biotechnology, biomedicine, and basic research. Glycomics is a widely emerging scientific field highlighting defining functional aspects of glycans in biosystems. Download Free Sample: https://www.datamintelligence.com/download-sample/glycomics-and- glycobiology-market Market Dynamics The global glycomics/glycobiology market growth is driven by the increasing research activities on glycomics, rising R&D investments in pharmaceutical and biotechnology companies, growth in the proteomics market. The rising number of government's initiatives to increase funding for R&D is expected to drive growth in the forecast period Increasing drug discovery and development is leading to a rise in R&D investments by biotech companies. Thus, the need for glycomics research techniques for conducting comprehensive glycomes studies is constantly increasing. The increase in the government's number of initiatives to increase funding for R&D has led to the increased need for glycomics techniques. The Australian government invested around USD 10.4 billion in scientific research activities and innovations for 2017-2018. The Irish Government also announced a USD 5.6 billion spending program in 2015, which aimed to increase the number of scientific research activities from 25,000 to 40,000. Such funding initiatives are expected to propel the demand for glycomics research techniques in the near future. Key companies are also undertaking extensive R&D initiatives to develop new and technologically advanced products. For instance, in 2018, Shimadzu Corp. collaborated with PREMIER Biosoft, a global company in the field of bioinformatics solutions, with an aim to introduce its LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry system for advanced glycomics

2. and lipidomics data research analysis. In addition, in 2016, ProZyme, Inc. launched Gly-Q Glycan Analysis System, an integrated platform that enables user-friendly and high-throughput glycoanalysis. The high cost of tools is likely to hamper the market growth The high cost of tools like Glycan Array Kit cost around $1,201.79 - $1,916.32 is expected to hamper the market growth. COVID-19 Impact Analysis Pharmaceutical and biotech companies, together with governments around the globe, are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the need for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness significant growth in the future. Segment Analysis The mass spectrometry instruments segment is expected to hold the largest share in this market segment Mass spectrometry instruments are the largest and the fastest-growing product segment in the market, majorly due to the high advantages. Mass Spectrometry (MS) has been recognized as a valuable technique for quantifying proteins in the clinical chemistry laboratory. The advantage of MS is its increased analytical specificity over conventional detection methods. MS-based methods allow for the unequivocal identification of glycans, peptides, and glycopeptides through the unique combination of precursor mass and fragmentation patterns. As such, the technique allows for the molecular characterization of proteins (the proteoforms), including the presence of specific glycoforms. The measurand of a test can, thus, be defined much more accurately using MS, as compared to using activity- or immunoassays, that are typically ‘blind’ to the individual proteins. Moreover, MS is widely used in free oligosaccharides, glycosaminoglycans, and the glycan portions of glycoproteins, proteoglycans, and glycolipids. And there is a wide range of MS techniques available for glycomics analysis. For instance, On June 4, 2018, Shimadzu Corp. and PREMIER Biosoft introduced its LCMS-9030 Quadruple Time of Flight (Q-TOF) mass spectrometry system. Geographical Analysis North America region holds the largest market share of the global glycomics/ glycobiology market North America is expected to dominate the global market, followed by Europe. The largest share of North America is mainly attributed to increasing product launches in glycan analysis systems. For instance, on November 15, 2016, ProZyme, Inc. launched Gly-Q Glycan Analysis System which is an integrated platform that is a user-friendly glycoanalysis. Furthermore, the US government spends a significant percentage of its GDP on R&D. According to a 2018 report published by the Organization for Economic Co-operation and Development (OECD), about 2.82% of the country’s GDP was spent on R&D. In addition, in 2019, the research and development (R&D) expenditure of the US pharmaceutical industry was around USD 83 billion up from USD 79.6 billion in 2018 and USD 71.4

3. billion in 2017. Thus, increasing R&D activities increase the demand for mass spectrometers and drive market growth. Competitive Landscape The global glycomics/glycobiology market is highly competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Merck KGaA, Agilent Technologies, Thermo Fisher Scientific, New England Biolabs, Shimadzu Corporation, Waters Corporation, Asparia Glycomics S.L, Bruker Corporation, Chemily Glycoscience, and Dextra Laboratories. Why Purchase the Report? • Visualize the composition of the glycomics/glycobiology market segmentation by product, application, end-user, and region highlighting the key commercial assets and players. • Identify commercial opportunities in the glycomics/glycobiology market by analyzing trends and co-development deals. • Excel data sheet with thousands of data points of glycomics/glycobiology market-level 4/5 segmentation. • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study. • Product mapping in excel for the key product of all major market players. Target Audience •Service Providers/ Buyers •Industry Investors/Investment Bankers •Education & Research Institutes •Research Professionals •Emerging Companies •Manufacturers About Us DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world. For more information: Sai Kiran Sales Manager at DataM Intelligence Email: info@datamintelligence.com